The global pharmaceutical glycerin market was valued at $89.89 million in 2020, and is projected to reach $246.48 million by 2030, registering a CAGR of 11.0% from 2021 to 2030.
The total volume of global pharmaceutical glycerin market was 132,000 tons in 2020, and is projected to reach 243,641 tons by 2030, registering a CAGR of 6.6% from 2021 to 2030.
Glycerol is a colorless syrupy liquid that is used medically as a laxative, given orally as an enema, or in the form of suppositories. Glycerol has multiple uses in food, chemical, pharmaceutical, and biotechnological industries as a sweetener, a humectant, a solvent, or as feeding stock for microbial cultures.
The pharmaceutical glycerin market is witnessing tremendous growth, owing to antimicrobial and antiviral properties. It is widely used in pharmaceutical preparations as a means of improving smoothness, providing lubrication, and treating skin damage. It also finds its application in allergen immunotherapies, cough syrups, elixirs and expectorants, glycerin soaps, and water-based personal lubricants. Nitro-glycerin is one of the most common treatments for treating chronic angina, chest pain, and heart disease. The medication of Glycerin is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations in the healthcare industry. Growth in demand for glycerin in the pharmaceutical industry. Glycerin is used as a humectant and emollient in skincare, hair care, oral care, and cosmetics among others to enhance physical texture, inducing keratinocyte proliferation, healing wounds, and reducing melanin intensity. In addition, growing skincare and beauty & personal care industry, coupled with aging population and increasing self-consciousness are some of the additional factors anticipated to contribute toward the market growth. Apart from this, high demand for glycerin in the personal care and cosmetics industry is also estimated to accelerate growth of the market during the forecast period. Glycerin is used widely in hand sanitizers and in oral healthcare products. Owing to the COVID-19 pandemic, demand for hand sanitizers witnessed a massive surge, thereby leading to rise in need among manufacturers of hand sanitizers to source glycerin in high quantities. On the other hand, increase in oral health diseases globally, which according to the statistics by the World Health Organization (WHO) is recorded to affect 3.5 Billion people, is also anticipated to propel the market growth.
Rise in inclination of consumers toward natural personal care and cosmetics products is set to propel the glycerin market growth in the coming years. This mainly occurs, owing to increasing awareness programs among masses regarding harmful effects of chemical ingredients.
The pharmaceutical glycerin market in this report is studied on the basis of application and region. On the basis of application, the market is divided as excipient and glycerin as a care product. Excipients are further divided into fillers & plasticizer, solubilizer & emulsifier, solvent, diluent & base, lubricant, thickener, and sweetener. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, Asia-Pacific dominated the market in 2020, and is expected to maintain it in the forecast period, owing to the high presence of top glycerin-producing countries such as Malaysia, Indonesia, India, and Japan has resulted in a competitive environment in terms of production technologies and securing production capacities in the region. Also, on account of the favorable growth of end-use industries in China, India, and South East Asia, the region is expected to register the fastest growth during the foreseeable period.
The major players operating in the Global Pharmaceutical Glycerin market are Archer Daniels Midland Company, Cargill Inc., DuPont de Nemours, Inc., Emery Oleo chemicals Group, Godrej Group, Procter and Gamble Co., Reagents, Renewable Energy Group Inc., The Chemical Company, and Universal Preserv-A-Chem, Inc. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
The total volume of global pharmaceutical glycerin market was 132,000 tons in 2020, and is projected to reach 243,641 tons by 2030, registering a CAGR of 6.6% from 2021 to 2030.
Glycerol is a colorless syrupy liquid that is used medically as a laxative, given orally as an enema, or in the form of suppositories. Glycerol has multiple uses in food, chemical, pharmaceutical, and biotechnological industries as a sweetener, a humectant, a solvent, or as feeding stock for microbial cultures.
The pharmaceutical glycerin market is witnessing tremendous growth, owing to antimicrobial and antiviral properties. It is widely used in pharmaceutical preparations as a means of improving smoothness, providing lubrication, and treating skin damage. It also finds its application in allergen immunotherapies, cough syrups, elixirs and expectorants, glycerin soaps, and water-based personal lubricants. Nitro-glycerin is one of the most common treatments for treating chronic angina, chest pain, and heart disease. The medication of Glycerin is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations in the healthcare industry. Growth in demand for glycerin in the pharmaceutical industry. Glycerin is used as a humectant and emollient in skincare, hair care, oral care, and cosmetics among others to enhance physical texture, inducing keratinocyte proliferation, healing wounds, and reducing melanin intensity. In addition, growing skincare and beauty & personal care industry, coupled with aging population and increasing self-consciousness are some of the additional factors anticipated to contribute toward the market growth. Apart from this, high demand for glycerin in the personal care and cosmetics industry is also estimated to accelerate growth of the market during the forecast period. Glycerin is used widely in hand sanitizers and in oral healthcare products. Owing to the COVID-19 pandemic, demand for hand sanitizers witnessed a massive surge, thereby leading to rise in need among manufacturers of hand sanitizers to source glycerin in high quantities. On the other hand, increase in oral health diseases globally, which according to the statistics by the World Health Organization (WHO) is recorded to affect 3.5 Billion people, is also anticipated to propel the market growth.
Rise in inclination of consumers toward natural personal care and cosmetics products is set to propel the glycerin market growth in the coming years. This mainly occurs, owing to increasing awareness programs among masses regarding harmful effects of chemical ingredients.
The pharmaceutical glycerin market in this report is studied on the basis of application and region. On the basis of application, the market is divided as excipient and glycerin as a care product. Excipients are further divided into fillers & plasticizer, solubilizer & emulsifier, solvent, diluent & base, lubricant, thickener, and sweetener. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, Asia-Pacific dominated the market in 2020, and is expected to maintain it in the forecast period, owing to the high presence of top glycerin-producing countries such as Malaysia, Indonesia, India, and Japan has resulted in a competitive environment in terms of production technologies and securing production capacities in the region. Also, on account of the favorable growth of end-use industries in China, India, and South East Asia, the region is expected to register the fastest growth during the foreseeable period.
The major players operating in the Global Pharmaceutical Glycerin market are Archer Daniels Midland Company, Cargill Inc., DuPont de Nemours, Inc., Emery Oleo chemicals Group, Godrej Group, Procter and Gamble Co., Reagents, Renewable Energy Group Inc., The Chemical Company, and Universal Preserv-A-Chem, Inc. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
Key Benefits For Stakeholders
- This report provides a quantitativepharmaceutical glycerine market analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical glycerine market size analysis from 2020 to 2030 to identify the prevailing pharmaceutical glycerine market opportunities.
- Pharmaceutical glycerine market trends from various industries and countries have been studied for understanding individual demand and supply patterns.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pharmaceutical glycerine market opportunity segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pharmaceutical glycerine market growth trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Application
- Excipient
- Glycerin As Care Product
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- DuPont
- cargill
- Universal Preserv A Chem Inc.
- TCC Glycerin
- Procter and Gamble Co
- Godrej Group
- Emery Oleochemicals Group
- Archer Daniels Midland Company
- Renewable Energy Group, Inc.
- Reagents Company
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION
CHAPTER 5: PHARMACEUTICAL GLYCERINE MARKET, BY REGION
CHAPTER 6: COMPANY LANDSCAPE
CHAPTER 7: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Pharmaceutical Glycerine Market,' the pharmaceutical glycerine market size was valued at $89.89 million in 2020, and is estimated to reach $246.48 million by 2030, growing at a CAGR of 11% from 2021 to 2030. The total volume of global Pharmaceutical Glycerine Market share was estimated to be 132,000 tons in 2020, and is projected to reach 243,641 tons by 2030, registering a CAGR of 6.6% from 2021 to 2030.As an individual prescription product, glycerin has uses as hyperosmotic, osmotic diuretic, and ophthalmic agent. It may be used as eye drop in treatment of glaucoma to reduce intraocular pressure, as a solution or suppository for short-term treatment of constipation, to evacuate bowel prior to colonoscopy, and in some ocular surgeries. It may be given intravenously to reduce pressure inside the brain and used externally on the skin as a moisturizer. Glycerin has many other uses in agricultural, food, and pharmaceutical industries.
The U.S. Food and Drug Administration (FDA) classify glycerin as 'generally recognized as safe” (GRAS). The overall risk of toxicity from glycerin found in pharmaceutical products is low. If one were to come into contact with large, bulk quantities of glycerin, eye irritation may occur. Skin irritation is unlikely unless the skin is damaged where contact occurs. Inhalational toxicity is low due to low volatility, but prolonged, excessive ingestion can cause elevated blood sugar or fat levels in the blood.
The global healthcare landscape has been changing rapidly and people are spending more on health-related needs. With people getting more health conscious and increasing ageing population, demand for pharmaceuticals has been increasing around the globe, which, in turn, has led to high consumption of pharmaceutical ingredients and raw materials. Thus, with this increase in production of pharmaceutical products, demand for raw materials such as glycerin is expected to increase during the forecast period. There has also been a rise in adoption of glycerin in pharmaceutical industry owing to its low cost and various medical benefits such as moisturizer in skin burns & minor skin irritations and in treatment of constipation.
However, adverse effects of pharmaceutical glycerin, such as diarrhea, polyuria, nausea, dry mouth, and others hinder the market growth. Ongoing R&D activities related to pharmaceutical glycerin are anticipated to present new opportunities for the market.
The pharmaceutical glycerine Industry is segmented on the basis of application and region. On the basis of application, the excipient segment currently dominates the market, and is expected to continue during the forecast period, owing to rise in demand for eyewash solutions and as glycerin is a predominant excipient for pharmaceutical products.
On the basis of excipients, the solubilizer & emulsifier segment dominated the Global Pharmaceutical Glycerin market in 2020 and is anticipated to be dominant in the market as they are being used to increase oral bioavailability of Class II and Class IV drugs.
Asia-Pacific dominated the market in 2020, owing to healthy growth of industries such as pharmaceutical and personal care. Low production cost, labor cost, and lenient regulations in these regions are encouraging manufacturers to expand their manufacturing [S1] facilities in these regions, which, in turn, is expected to drive demand for glycerin. Thus, such pharmaceutical glycerine market trends in Asia Pacific region will create lucrative opportunities during the analysis period.
Companies Mentioned
- DuPont
- cargill
- Universal Preserv A Chem Inc.
- TCC Glycerin
- Procter and Gamble Co
- Godrej Group
- Emery Oleochemicals Group
- Archer Daniels Midland Company
- Renewable Energy Group, Inc.
- Reagents Company
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 89.89 million |
| Forecasted Market Value ( USD | $ 246.48 million |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
